Short answer
Cencora (COR) filed an 8-K current report with the SEC on August 12, 2026 reporting Item 7.01 (Regulation FD Disclosure). Walgreens-related volume outside the prime vendor agreement began shifting away July 1, 2026.
Cencora 8-K event analysis
AI summary of each reported item and its exhibits
Item 7.01 · Regulation FD Disclosure
- Walgreens-related volume outside the prime vendor agreement began shifting away July 1, 2026
- Prime vendor agreement unchanged and still represents the vast majority of Cencora’s Walgreens business
- Management had already incorporated the transition into fourth-quarter U.S. Healthcare Solutions expectations
- Fiscal 2026 adjusted diluted EPS guidance reaffirmed at $17.75–$17.95
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Cencora 8-K filings
Get the next COR 8-K as it lands
Follow COR for push alerts, or ask the research agent what this filing means.